15 | Carcinoembryonic AntigenIBA
01/2024
-
04/2004 |
15 | AntigensIBA
02/2023
-
12/2003 |
13 | AntibodiesIBA
01/2024
-
12/2003 |
9 | Immunoglobulin FragmentsIBA
09/2017
-
12/2003 |
6 | Monoclonal AntibodiesIBA
11/2023
-
05/2004 |
4 | Proteins (Proteins, Gene)FDA Link
02/2024
-
01/2007 |
4 | Coloring Agents (Dyes)IBA
01/2024
-
10/2017 |
4 | Radioisotopes (Radionuclides)IBA
01/2021
-
12/2003 |
4 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2017
-
07/2010 |
3 | Immunoglobulin G (IgG)IBA
01/2024
-
07/2010 |
3 | Glycoproteins (Glycoprotein)IBA
01/2021
-
07/2010 |
3 | Sulfhydryl Compounds (Thiols)IBA
04/2017
-
01/2008 |
2 | Interleukin-2 (IL2)IBA
02/2024
-
12/2022 |
2 | Therapeutic UsesIBA
08/2023
-
01/2022 |
2 | (2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA
08/2023
-
01/2022 |
2 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2022
-
01/2021 |
2 | Tumor Biomarkers (Tumor Markers)IBA
01/2022
-
01/2021 |
2 | tumor-associated antigen 72IBA
09/2020
-
01/2020 |
2 | Fluorescent Dyes (Fluorescent Probes)IBA
12/2018
-
04/2018 |
2 | Lipid NanoparticlesIBA
09/2017
-
04/2017 |
2 | LigandsIBA
04/2017
-
06/2011 |
2 | Cysteine (L-Cysteine)FDA Link
04/2017
-
01/2004 |
1 | Calcibiotic Root Canal SealerIBA
08/2023 |
1 | Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2023 |
1 | AdamantaneIBA
01/2023 |
1 | 2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2022 |
1 | InterferonsIBA
12/2022 |
1 | Muromonab-CD3 (Muromonab CD3)FDA Link
02/2022 |
1 | RNA (Ribonucleic Acid)IBA
02/2022 |
1 | SolutionsIBA
02/2022 |
1 | ferroceneIBA
01/2022 |
1 | daratumumabIBA
01/2021 |
1 | IRDye800IBA
09/2020 |
1 | Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2020 |
1 | LipidsIBA
01/2020 |
1 | Phospholipids (Phosphatides)FDA LinkGeneric
01/2020 |
1 | Cell Surface ReceptorsIBA
12/2019 |
1 | Green Fluorescent ProteinsIBA
04/2018 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
09/2017 |
1 | auristatinIBA
09/2017 |
1 | 1,2-distearoylphosphatidylethanolamine (DSPE)IBA
04/2017 |
1 | EstersIBA
04/2017 |
1 | MicellesIBA
04/2017 |
1 | maleimideIBA
04/2017 |
1 | PolymersIBA
04/2017 |
1 | STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
04/2016 |
1 | Interleukin-6 (Interleukin 6)IBA
04/2016 |
1 | Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
04/2016 |
1 | MucinsIBA
01/2015 |
1 | CTLA-4 AntigenIBA
01/2015 |
1 | CEACAM1 ProteinIBA
01/2015 |
1 | CytokinesIBA
01/2015 |
1 | Bispecific AntibodiesIBA
03/2013 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
06/2011 |
1 | Lysine (L-Lysine)FDA Link
04/2011 |
1 | IsotopesIBA
04/2011 |
1 | Trastuzumab (Herceptin)FDA Link
12/2009 |
1 | Immunoglobulins (Immunoglobulin)IBA
12/2009 |
1 | AlbuminsIBA
02/2008 |
1 | Humanized Monoclonal AntibodiesIBA
01/2008 |
1 | Neoplasm Antigens (Tumor Antigens)IBA
01/2006 |
1 | indium- 111- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetraacetic acidIBA
07/2005 |
1 | Indicators and Reagents (Reagents)IBA
05/2004 |
1 | DisulfidesIBA
01/2004 |
1 | Fluorouracil (Carac)FDA LinkGeneric
12/2003 |